The public cost of 3 statins for primary prevention of cardiovascular events in 7 Middle East countries: Not all of them can afford it
Gespeichert in:
Veröffentlicht in: | International journal of cardiology 2012-03, Vol.155 (2), p.316-318 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 318 |
---|---|
container_issue | 2 |
container_start_page | 316 |
container_title | International journal of cardiology |
container_volume | 155 |
creator | Isma'eel, Hussain Mohanna, Zeina Hamadeh, Ghassan Alam, Elie Badr, Kamal Alam, Samir Rebeiz, Abdallah |
description | |
doi_str_mv | 10.1016/j.ijcard.2011.12.011 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_921425114</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0167527311021711</els_id><sourcerecordid>921425114</sourcerecordid><originalsourceid>FETCH-LOGICAL-c446t-8007c8daa5a951ed378a0655f3fe9daa46b6b40663d919400f756baa9da71e173</originalsourceid><addsrcrecordid>eNqFUsFu1DAQtRCIbgt_gJAviFOCJ3HshAMSqlpAKnCgnC3HnqhesvZiOyv1B_huHHYBiQu-PMnz5r3RmyHkGbAaGIhX29ptjY62bhhADU1d4AHZQC95BbLjD8mm0GTVNbI9I-cpbRljfBj6x-SsaRqQvBcb8uP2Dul-GWdnqAkp0zDRlqass_OJTiHSfXQ7He8L4gF9dsGvnNXZhYNOZpl1pL9KiTpPJf3orJ2RXumiZsLic3SYXtNPIVM9z2tzvsNdUfBUT8XBUpefkEeTnhM-PeEF-Xp9dXv5vrr5_O7D5dubynAuctUzJk1vte700AHaVvaaia6b2gmH8s3FKEbOhGjtAANnbJKdGLUuNQkIsr0gL4-6-xi-L5iy2rlkcJ61x7AkNTTAmw6AFyY_Mk0MKUWc1CkIBUytC1BbdVyAWhegoFEFStvzk8Ey7tD-afqdeCG8OBFKdnqeovbGpb-8TpTHVqE3Rx6WOA4Oo0rGoTdoXUSTlQ3uf5P8K2Bm513x_Ib3mLZhib5ErUCl0qC-rMey3goAK6MWgZ_-zrrH</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>921425114</pqid></control><display><type>article</type><title>The public cost of 3 statins for primary prevention of cardiovascular events in 7 Middle East countries: Not all of them can afford it</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Isma'eel, Hussain ; Mohanna, Zeina ; Hamadeh, Ghassan ; Alam, Elie ; Badr, Kamal ; Alam, Samir ; Rebeiz, Abdallah</creator><creatorcontrib>Isma'eel, Hussain ; Mohanna, Zeina ; Hamadeh, Ghassan ; Alam, Elie ; Badr, Kamal ; Alam, Samir ; Rebeiz, Abdallah</creatorcontrib><identifier>ISSN: 0167-5273</identifier><identifier>EISSN: 1874-1754</identifier><identifier>DOI: 10.1016/j.ijcard.2011.12.011</identifier><identifier>PMID: 22217486</identifier><identifier>CODEN: IJCDD5</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>Biological and medical sciences ; Cardiology. Vascular system ; Cardiovascular ; Cardiovascular Diseases - drug therapy ; Cardiovascular Diseases - epidemiology ; Cardiovascular Diseases - prevention & control ; Cost ; Developing Countries - economics ; Developing Countries - statistics & numerical data ; Drug Costs - statistics & numerical data ; Health Care Costs - statistics & numerical data ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors - economics ; Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use ; Medical sciences ; Middle East - epidemiology ; Prevention ; Primary ; Statin</subject><ispartof>International journal of cardiology, 2012-03, Vol.155 (2), p.316-318</ispartof><rights>Elsevier Ireland Ltd</rights><rights>2011 Elsevier Ireland Ltd</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c446t-8007c8daa5a951ed378a0655f3fe9daa46b6b40663d919400f756baa9da71e173</citedby><cites>FETCH-LOGICAL-c446t-8007c8daa5a951ed378a0655f3fe9daa46b6b40663d919400f756baa9da71e173</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0167527311021711$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25666601$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22217486$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Isma'eel, Hussain</creatorcontrib><creatorcontrib>Mohanna, Zeina</creatorcontrib><creatorcontrib>Hamadeh, Ghassan</creatorcontrib><creatorcontrib>Alam, Elie</creatorcontrib><creatorcontrib>Badr, Kamal</creatorcontrib><creatorcontrib>Alam, Samir</creatorcontrib><creatorcontrib>Rebeiz, Abdallah</creatorcontrib><title>The public cost of 3 statins for primary prevention of cardiovascular events in 7 Middle East countries: Not all of them can afford it</title><title>International journal of cardiology</title><addtitle>Int J Cardiol</addtitle><subject>Biological and medical sciences</subject><subject>Cardiology. Vascular system</subject><subject>Cardiovascular</subject><subject>Cardiovascular Diseases - drug therapy</subject><subject>Cardiovascular Diseases - epidemiology</subject><subject>Cardiovascular Diseases - prevention & control</subject><subject>Cost</subject><subject>Developing Countries - economics</subject><subject>Developing Countries - statistics & numerical data</subject><subject>Drug Costs - statistics & numerical data</subject><subject>Health Care Costs - statistics & numerical data</subject><subject>Humans</subject><subject>Hydroxymethylglutaryl-CoA Reductase Inhibitors - economics</subject><subject>Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use</subject><subject>Medical sciences</subject><subject>Middle East - epidemiology</subject><subject>Prevention</subject><subject>Primary</subject><subject>Statin</subject><issn>0167-5273</issn><issn>1874-1754</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUsFu1DAQtRCIbgt_gJAviFOCJ3HshAMSqlpAKnCgnC3HnqhesvZiOyv1B_huHHYBiQu-PMnz5r3RmyHkGbAaGIhX29ptjY62bhhADU1d4AHZQC95BbLjD8mm0GTVNbI9I-cpbRljfBj6x-SsaRqQvBcb8uP2Dul-GWdnqAkp0zDRlqass_OJTiHSfXQ7He8L4gF9dsGvnNXZhYNOZpl1pL9KiTpPJf3orJ2RXumiZsLic3SYXtNPIVM9z2tzvsNdUfBUT8XBUpefkEeTnhM-PeEF-Xp9dXv5vrr5_O7D5dubynAuctUzJk1vte700AHaVvaaia6b2gmH8s3FKEbOhGjtAANnbJKdGLUuNQkIsr0gL4-6-xi-L5iy2rlkcJ61x7AkNTTAmw6AFyY_Mk0MKUWc1CkIBUytC1BbdVyAWhegoFEFStvzk8Ey7tD-afqdeCG8OBFKdnqeovbGpb-8TpTHVqE3Rx6WOA4Oo0rGoTdoXUSTlQ3uf5P8K2Bm513x_Ib3mLZhib5ErUCl0qC-rMey3goAK6MWgZ_-zrrH</recordid><startdate>20120308</startdate><enddate>20120308</enddate><creator>Isma'eel, Hussain</creator><creator>Mohanna, Zeina</creator><creator>Hamadeh, Ghassan</creator><creator>Alam, Elie</creator><creator>Badr, Kamal</creator><creator>Alam, Samir</creator><creator>Rebeiz, Abdallah</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120308</creationdate><title>The public cost of 3 statins for primary prevention of cardiovascular events in 7 Middle East countries: Not all of them can afford it</title><author>Isma'eel, Hussain ; Mohanna, Zeina ; Hamadeh, Ghassan ; Alam, Elie ; Badr, Kamal ; Alam, Samir ; Rebeiz, Abdallah</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c446t-8007c8daa5a951ed378a0655f3fe9daa46b6b40663d919400f756baa9da71e173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Biological and medical sciences</topic><topic>Cardiology. Vascular system</topic><topic>Cardiovascular</topic><topic>Cardiovascular Diseases - drug therapy</topic><topic>Cardiovascular Diseases - epidemiology</topic><topic>Cardiovascular Diseases - prevention & control</topic><topic>Cost</topic><topic>Developing Countries - economics</topic><topic>Developing Countries - statistics & numerical data</topic><topic>Drug Costs - statistics & numerical data</topic><topic>Health Care Costs - statistics & numerical data</topic><topic>Humans</topic><topic>Hydroxymethylglutaryl-CoA Reductase Inhibitors - economics</topic><topic>Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use</topic><topic>Medical sciences</topic><topic>Middle East - epidemiology</topic><topic>Prevention</topic><topic>Primary</topic><topic>Statin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Isma'eel, Hussain</creatorcontrib><creatorcontrib>Mohanna, Zeina</creatorcontrib><creatorcontrib>Hamadeh, Ghassan</creatorcontrib><creatorcontrib>Alam, Elie</creatorcontrib><creatorcontrib>Badr, Kamal</creatorcontrib><creatorcontrib>Alam, Samir</creatorcontrib><creatorcontrib>Rebeiz, Abdallah</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Isma'eel, Hussain</au><au>Mohanna, Zeina</au><au>Hamadeh, Ghassan</au><au>Alam, Elie</au><au>Badr, Kamal</au><au>Alam, Samir</au><au>Rebeiz, Abdallah</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The public cost of 3 statins for primary prevention of cardiovascular events in 7 Middle East countries: Not all of them can afford it</atitle><jtitle>International journal of cardiology</jtitle><addtitle>Int J Cardiol</addtitle><date>2012-03-08</date><risdate>2012</risdate><volume>155</volume><issue>2</issue><spage>316</spage><epage>318</epage><pages>316-318</pages><issn>0167-5273</issn><eissn>1874-1754</eissn><coden>IJCDD5</coden><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>22217486</pmid><doi>10.1016/j.ijcard.2011.12.011</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0167-5273 |
ispartof | International journal of cardiology, 2012-03, Vol.155 (2), p.316-318 |
issn | 0167-5273 1874-1754 |
language | eng |
recordid | cdi_proquest_miscellaneous_921425114 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Biological and medical sciences Cardiology. Vascular system Cardiovascular Cardiovascular Diseases - drug therapy Cardiovascular Diseases - epidemiology Cardiovascular Diseases - prevention & control Cost Developing Countries - economics Developing Countries - statistics & numerical data Drug Costs - statistics & numerical data Health Care Costs - statistics & numerical data Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - economics Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Medical sciences Middle East - epidemiology Prevention Primary Statin |
title | The public cost of 3 statins for primary prevention of cardiovascular events in 7 Middle East countries: Not all of them can afford it |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T01%3A09%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20public%20cost%20of%203%20statins%20for%20primary%20prevention%20of%20cardiovascular%20events%20in%207%20Middle%20East%20countries:%20Not%20all%20of%20them%20can%20afford%20it&rft.jtitle=International%20journal%20of%20cardiology&rft.au=Isma'eel,%20Hussain&rft.date=2012-03-08&rft.volume=155&rft.issue=2&rft.spage=316&rft.epage=318&rft.pages=316-318&rft.issn=0167-5273&rft.eissn=1874-1754&rft.coden=IJCDD5&rft_id=info:doi/10.1016/j.ijcard.2011.12.011&rft_dat=%3Cproquest_cross%3E921425114%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=921425114&rft_id=info:pmid/22217486&rft_els_id=S0167527311021711&rfr_iscdi=true |